TriSalus Life Sciences, Inc. (TLSI) Q4 2024 Earnings
TLSI·Reported March 27, 2025·Before market open
TriSalus Life Sciences, Inc. reported Q4 2024 revenue of $8.3M, beat analyst consensus of $8.1M by $145.0K. Diluted EPS came in at $-0.35.
Revenue
$8.3Mbeat by $145.0K
Consensus: $8.1MDiluted EPS
$-0.35met estimate
Consensus: $-0.35
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q4 2024 Earnings FAQ
Common questions about TriSalus Life Sciences, Inc.'s Q4 2024 earnings report.
TriSalus Life Sciences, Inc. (TLSI) reported Q4 2024 earnings on March 27, 2025 before market open.
TriSalus Life Sciences, Inc. reported revenue of $8.3M and diluted EPS of $-0.35 for Q4 2024.
Revenue beat the consensus estimate of $8.1M by $145.0K. EPS beat the consensus estimate of $-0.35 by $0.00.